Health TidingsOtsuka Study Suggests S-Equol May Help Women With Severe PMS and PMDD Otsuka Study Suggests S-Equol May Help Women With Severe PMS and PMDD Read Post »
Health TidingsNovel Oral HIV Capsid Inhibitor VH-499 Reduces Viral Load in Phase 2a Study Novel Oral HIV Capsid Inhibitor VH-499 Reduces Viral Load in Phase 2a Study Read Post »
Health TidingsTiziana Reports Third Phase 2 MSA Patient Shows Reduced Neuroinflammation o... Tiziana Reports Third Phase 2 MSA Patient Shows Reduced Neuroinflammation o... Read Post »
Clinical TrialsAnnamycin Maintains Blinded Remission Rates in Difficult-to-Treat AML Patie... Annamycin Maintains Blinded Remission Rates in Difficult-to-Treat AML Patie... Read Post »
Clinical TrialsZiltivekimab Fails to Reduce Cardiovascular Events in Phase III ZEUS Trial Ziltivekimab Fails to Reduce Cardiovascular Events in Phase III ZEUS Trial Read Post »
New Drug ApprovalEU Approves Datroway for Metastatic Triple-Negative Breast Cancer EU Approves Datroway for Metastatic Triple-Negative Breast Cancer Read Post »
Health TidingsAbivax Advances Obefazimod Toward FDA NDA for Ulcerative Colitis Abivax Advances Obefazimod Toward FDA NDA for Ulcerative Colitis Read Post »
Clinical TrialsFDA Advisory Panel Backs Replimune’s RP1 for Advanced Melanoma FDA Advisory Panel Backs Replimune’s RP1 for Advanced Melanoma Read Post »
Clinical TrialsKaryopharm Shifts Focus After Phase 3 Selinexor Trial Misses Primary Endpoi... Karyopharm Shifts Focus After Phase 3 Selinexor Trial Misses Primary Endpoi... Read Post »
Health Tidings Mergers & AcquisitionsAbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers AbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers Read Post »
New Drug ApprovalEU Approves Pfizer-BioNTech XFG COVID-19 Vaccine for 2026-2027 EU Approves Pfizer-BioNTech XFG COVID-19 Vaccine for 2026-2027 Read Post »
Health Tidings Mergers & AcquisitionsRelation, GSK Partner in $110M AI Drug Discovery Collaboration Relation, GSK Partner in $110M AI Drug Discovery Collaboration Read Post »
Health TidingsFDA Grants Priority Review to J&J’s Subcutaneous Amivantamab for ... FDA Grants Priority Review to J&J’s Subcutaneous Amivantamab for ... Read Post »
Health TidingsFDA Advisory Panel Recommends Against Deramiocel for DMD Cardiomyopathy FDA Advisory Panel Recommends Against Deramiocel for DMD Cardiomyopathy Read Post »
Health TidingsOmalizumab Outperformed Multiallergen Oral Immunotherapy in OUTMATCH Trial ... Omalizumab Outperformed Multiallergen Oral Immunotherapy in OUTMATCH Trial ... Read Post »
Clinical TrialsCTx-1301 Shows Significant ADHD Symptom Improvement in Phase 3 Trial CTx-1301 Shows Significant ADHD Symptom Improvement in Phase 3 Trial Read Post »
Clinical TrialsRalinepag Reduced Clinical Worsening Risk by 55% in Phase 3 PAH Trial Publi... Ralinepag Reduced Clinical Worsening Risk by 55% in Phase 3 PAH Trial Publi... Read Post »
Clinical TrialsPfizer’s LITFULO Meets Phase 3 Endpoints in Nonsegmental Vitiligo Pfizer’s LITFULO Meets Phase 3 Endpoints in Nonsegmental Vitiligo Read Post »
Health TidingsEyePoint Completes Enrollment in Phase 3 DURAVYU™ Trials for DME EyePoint Completes Enrollment in Phase 3 DURAVYU™ Trials for DME Read Post »
Mergers & AcquisitionsJohnson & Johnson Partners with Sail Biomedicines for In Vivo CAR-T The... Johnson & Johnson Partners with Sail Biomedicines for In Vivo CAR-T The... Read Post »
New Drug ApprovalTeleflex Receives FDA Approval for First Freeze-Dried Plasma Product in the... Teleflex Receives FDA Approval for First Freeze-Dried Plasma Product in the... Read Post »
Health TidingsMHRA and NICE Approve Aficamten for Obstructive Hypertrophic Cardiomyopathy MHRA and NICE Approve Aficamten for Obstructive Hypertrophic Cardiomyopathy Read Post »
Health TidingsFDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Site I... FDA Grants Priority Review to PolyPid’s D-PLEX100 for Surgical Site I... Read Post »
Clinical TrialsNEJM Publishes Positive Phase 2b Results for Latigo’s LTG-001 in Post... NEJM Publishes Positive Phase 2b Results for Latigo’s LTG-001 in Post... Read Post »
Clinical TrialsDeramiocel Significantly Slows Upper Limb Function Decline in Advanced Duch... Deramiocel Significantly Slows Upper Limb Function Decline in Advanced Duch... Read Post »
Clinical TrialsViiV Healthcare Strengthens Evidence for Long-Acting HIV Therapies with Pos... ViiV Healthcare Strengthens Evidence for Long-Acting HIV Therapies with Pos... Read Post »
Health TidingsEuropean Commission Approves Opzelura for Adults with Moderate Atopic Derma... European Commission Approves Opzelura for Adults with Moderate Atopic Derma... Read Post »
Health TidingsFDA Grants Fast Track Designation to Insilico Medicine’s AI-Designed ... FDA Grants Fast Track Designation to Insilico Medicine’s AI-Designed ... Read Post »
Clinical TrialsCMG901 Improves Survival in Global Phase III Trial for CLDN18.2-Positive Ad... CMG901 Improves Survival in Global Phase III Trial for CLDN18.2-Positive Ad... Read Post »
Health TidingsOral Semaglutide Reduces Heavy Drinking in Phase 2 Trial, Supporting Furthe... Oral Semaglutide Reduces Heavy Drinking in Phase 2 Trial, Supporting Furthe... Read Post »
Health TidingsRepatha Wins CHMP Backing to Expand Cardiovascular Risk Reduction in High-R... Repatha Wins CHMP Backing to Expand Cardiovascular Risk Reduction in High-R... Read Post »
Health TidingsEuropean Commission Approves RINVOQ for Severe Alopecia Areata and Non-Segm... European Commission Approves RINVOQ for Severe Alopecia Areata and Non-Segm... Read Post »
Health TidingsFDA Raises Efficacy Concerns Over Replimune’s RP1 Before Advisory Com... FDA Raises Efficacy Concerns Over Replimune’s RP1 Before Advisory Com... Read Post »
Clinical TrialsMannKind Advances Inhaled Nintedanib with Positive Phase 1b IPF Data MannKind Advances Inhaled Nintedanib with Positive Phase 1b IPF Data Read Post »
New Drug ApprovalFDA Approves Viatris’ Gwyn Lo Contraceptive Patch for Pregnancy Preve... FDA Approves Viatris’ Gwyn Lo Contraceptive Patch for Pregnancy Preve... Read Post »
Clinical TrialsAtea Reports Positive Phase 3 Results for BEM/RZR in Hepatitis C Atea Reports Positive Phase 3 Results for BEM/RZR in Hepatitis C Read Post »
Health TidingsLUCERNA Trial Evaluates New First-Line Combination for CLDN18.2-Positive Ga... LUCERNA Trial Evaluates New First-Line Combination for CLDN18.2-Positive Ga... Read Post »
Clinical TrialsSeaweed-Derived Fucoidan Improves BPH Symptoms in Randomized Clinical Trial Seaweed-Derived Fucoidan Improves BPH Symptoms in Randomized Clinical Trial Read Post »
Clinical TrialsCaliway Submits FDA IND for Phase 2 Trial of CBL-514 Plus Tirzepatide to Re... Caliway Submits FDA IND for Phase 2 Trial of CBL-514 Plus Tirzepatide to Re... Read Post »
Clinical TrialsEMA Clears Investigator-Initiated Phase 1b/2 Trial of LP-184 in Biomarker-S... EMA Clears Investigator-Initiated Phase 1b/2 Trial of LP-184 in Biomarker-S... Read Post »
Health TidingsFDA Grants Fast Track Designation to HAYA’s HTX-001 for nHCM FDA Grants Fast Track Designation to HAYA’s HTX-001 for nHCM Read Post »
Mergers & AcquisitionsCSL Reports Positive Phase 3b Results for ANDEMBRY in Children With HAE CSL Reports Positive Phase 3b Results for ANDEMBRY in Children With HAE Read Post »
Health TidingsREGENERA Shows Durable Benefits One Year After Lumpectomy REGENERA Shows Durable Benefits One Year After Lumpectomy Read Post »
Health TidingsOrganogenesis Publishes Positive Affinity Trial Results for Venous Leg Ulce... Organogenesis Publishes Positive Affinity Trial Results for Venous Leg Ulce... Read Post »
Health TidingsGSK’s Risvutatug Rezetecan Extends Progression-Free Survival in Phase III... GSK’s Risvutatug Rezetecan Extends Progression-Free Survival in Phase III... Read Post »
Clinical TrialsProMIS Reports Positive Phase 1b PMN310 Interim Results in Alzheimer’... ProMIS Reports Positive Phase 1b PMN310 Interim Results in Alzheimer’... Read Post »
Clinical TrialsAltimmune Reports Positive Phase 2 Results for Pemvidutide in Alcohol Use D... Altimmune Reports Positive Phase 2 Results for Pemvidutide in Alcohol Use D... Read Post »
Mergers & AcquisitionsEntera Bio Positions EB613 for Phase 3 Osteoporosis Studies Entera Bio Positions EB613 for Phase 3 Osteoporosis Studies Read Post »
Clinical TrialsOryzon Reports Positive Iadademstat Data in First-Line AML Oryzon Reports Positive Iadademstat Data in First-Line AML Read Post »
Health Tidings Mergers & AcquisitionsBioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... BioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... Read Post »
